Search

everythinglearnresearchcommunity

for

Search:↓

The MAPK/ERK pathway is crucial in controlling cell growth and death in finasteride-induced hypospadias.

GLABRA2 represses root hair formation by inhibiting a specific gene.

A specific molecular switch, driven by MAPK/ERK signaling, helps spiny mice heal wounds by regenerating skin instead of forming scars.

Key genes influence cashmere growth cycles, aiding goat breeding.

Tofacitinib effectively promotes hair regrowth in children with alopecia areata, but more research on long-term safety is needed.

Tideglusib helps heal wounds in older skin.

Thymic stromal lymphopoietin (TSLP) promotes hair growth by stimulating specific skin cells.

Different body areas have unique skin cell communication patterns, explaining why certain skin diseases occur in specific regions.

Researchers found three different ways drugs work to treat hair loss from alopecia areata and identified key factors for personalized treatment.

Melatonin affects cashmere growth in goats by influencing stem cell and certain signaling pathways.

Tannic acid helps wounds heal faster in rats by activating certain cell signals and reducing inflammation.

Mice without the Sept4/ARTS gene heal wounds better due to more stem cells that don't die easily.

The medicine Cyclosporin A might cause excessive hair growth by reducing a protein that controls hair growth.

Alternative treatments are needed when Tofacitinib alone fails for alopecia areata.

Understanding the APCDD1 gene can lead to new hair loss treatments.

ATP-sensitive potassium channels are important for hair growth.

Tyrosine kinases are important in skin autoimmune diseases and could be targets for new treatments.

The protein FLCN is involved in cellular cleanup and is regulated by ULK1.

TLR2 is crucial for hair growth and regeneration, and boosting it can help prevent hair loss.

Activating the Eda/Edar pathway improves wound healing by enhancing hair follicle growth.

Malt1 protease is essential for regulatory T cell function and could be targeted to boost antitumor immunity.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

TLR2 helps control hair growth and regeneration, and its reduction with age or obesity can impair hair growth.

Tofacitinib treatment significantly improved a patient's psoriasis, psoriatic arthritis, and alopecia universalis.

Targeted protein degraders show promise in treating cancer but need to target more diverse proteins.

Cyclosporin A promotes hair growth in mice and increases a protein linked to hair growth, but it may not work the same way in humans.

Inhibiting TYK2 can restore hair growth in alopecia areata.

CTIP2 may help in skin development and maintenance.

A patient with alopecia had hair regrowth with tofacitinib but developed a skin reaction, choosing to continue the treatment despite the side effect.